Dexrazoxane
(right click,save link as to download,it is a temp file,please download as soon as possible, you can also use CTRL+S to save the whole html page)
Basic Info
Common Name | Dexrazoxane(F04751) |
2D Structure | |
Description | An antimitotic agent with immunosuppressive properties. Dexrazoxane, the (+)-enantiomorph of razoxane, provides cardioprotection against anthracycline toxicity. It appears to inhibit formation of a toxic iron-anthracycline complex. The Food and Drug Administration has designated dexrazoxane as an orphan drug for use in the prevention or reduction in the incidence and severity of anthracycline-induced cardiomyopathy. |
FRCD ID | F04751 |
CAS Number | 24584-09-6 |
PubChem CID | 71384 |
Formula | C11H16N4O4 |
IUPAC Name | 4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione |
InChI Key | BMKDZUISNHGIBY-ZETCQYMHSA-N |
InChI | InChI=1S/C11H16N4O4/c1-7(15-5-10(18)13-11(19)6-15)2-14-3-8(16)12-9(17)4-14/h7H,2-6H2,1H3,(H,12,16,17)(H,13,18,19)/t7-/m0/s1 |
Canonical SMILES | CC(CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2 |
Isomeric SMILES | C[C@@H](CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2 |
Wikipedia | Dexrazoxane |
Synonyms | (S)-4,4'-(Propane-1,2-diyl)bis(piperazine-2,6-dione) Dexrazoxane 24584-09-6 Zinecard ICRF-187 Cardioxane Dexrazoxano Dexrazoxanum Dextrorazoxane Dexrazoxanum [INN-Latin] |
Classifies | Predicted: Veterinary Drug |
Update Date | Nov 13, 2018 17:07 |
Chemical Taxonomy
Kingdom | Organic compounds |
Superclass | Organic acids and derivatives |
Class | Carboxylic acids and derivatives |
Subclass | Amino acids, peptides, and analogues |
Intermediate Tree Nodes | Amino acids and derivatives |
Direct Parent | Alpha amino acids and derivatives |
Alternative Parents | |
Molecular Framework | Aliphatic heteromonocyclic compounds |
Substituents | Alpha-amino acid or derivatives - Dioxopiperazine - N-alkylpiperazine - 1,4-diazinane - Piperazine - Carboxylic acid imide - Dicarboximide - Carboxylic acid imide, n-unsubstituted - Tertiary aliphatic amine - Tertiary amine - Organoheterocyclic compound - Azacycle - Organic nitrogen compound - Organooxygen compound - Organonitrogen compound - Amine - Organic oxygen compound - Hydrocarbon derivative - Organic oxide - Carbonyl group - Organopnictogen compound - Aliphatic heteromonocyclic compound |
Description | This compound belongs to the class of organic compounds known as alpha amino acids and derivatives. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon), or a derivative thereof. |
Properties
Property Name | Property Value |
---|---|
Molecular Weight | 268.273 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 3 |
Complexity | 404 |
Monoisotopic Mass | 268.117 |
Exact Mass | 268.117 |
XLogP | -1.4 |
Formal Charge | 0 |
Heavy Atom Count | 19 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
ADMET
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.6387 |
Human Intestinal Absorption | HIA+ | 0.8518 |
Caco-2 Permeability | Caco2- | 0.6144 |
P-glycoprotein Substrate | Substrate | 0.8766 |
P-glycoprotein Inhibitor | Inhibitor | 0.6576 |
Non-inhibitor | 0.9653 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.7348 |
Distribution | ||
Subcellular localization | Lysosome | 0.5380 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8399 |
CYP450 2D6 Substrate | Non-substrate | 0.7872 |
CYP450 3A4 Substrate | Substrate | 0.5139 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.9458 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8828 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9348 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.7777 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9666 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9741 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9410 |
Non-inhibitor | 0.8929 | |
AMES Toxicity | Non AMES toxic | 0.9132 |
Carcinogens | Non-carcinogens | 0.9077 |
Fish Toxicity | Low FHMT | 0.6662 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.8421 |
Honey Bee Toxicity | Low HBT | 0.8736 |
Biodegradation | Not ready biodegradable | 0.9910 |
Acute Oral Toxicity | III | 0.7343 |
Carcinogenicity (Three-class) | Warning | 0.5287 |
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -2.0191 | LogS |
Caco-2 Permeability | 0.5037 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 2.4267 | LD50, mol/kg |
Fish Toxicity | 2.3102 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 0.1128 | pIGC50, ug/L |
References
Title | Journal | Date | Pubmed ID |
---|---|---|---|
The iron chelator Dp44mT inhibits the proliferation of cancer cells but fails to protect from doxorubicin-induced cardiotoxicity in spontaneously hypertensive rats. | Cancer Chemother Pharmacol | 2011 Nov | 21373894 |
Targets
- General Function:
- Ubiquitin binding
- Specific Function:
- Control of topological states of DNA by transient breakage and subsequent rejoining of DNA strands. Topoisomerase II makes double-strand breaks. Essential during mitosis and meiosis for proper segregation of daughter chromosomes. May play a role in regulating the period length of ARNTL/BMAL1 transcriptional oscillation (By similarity).
- Gene Name:
- TOP2A
- Uniprot ID:
- P11388
- Molecular Weight:
- 174383.88 Da
- Mechanism of Action:
- The mechanism by which dexrazoxane exerts its cardioprotective activity is not fully understood. Dexrazoxane is a cyclic derivative of EDTA that readily penetrates cell membranes. Results of laboratory studies suggest that dexrazoxane is converted intracellularly to a ring-opened chelating agent that interferes with iron-mediated free radical generation thought to be responsible, in part, for anthracycline-induced cardiomyopathy.
References
- Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. [11752352 ]
- General Function:
- Protein kinase c binding
- Specific Function:
- Control of topological states of DNA by transient breakage and subsequent rejoining of DNA strands. Topoisomerase II makes double-strand breaks.
- Gene Name:
- TOP2B
- Uniprot ID:
- Q02880
- Molecular Weight:
- 183265.825 Da
References
- Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [17139284 ]